Clinical trial
Prader-Willi Syndrome and Appetite
NCT00175305 · University of British Columbia, Other · Terminated
Key facts
| NCT number | NCT00175305 |
|---|---|
| Title | Prader-Willi Syndrome and Appetite |
| Official title | Effect of Somatostatin on Ghrelin Concentrations, Food Seeking Behaviour and Weight in Patients With Prader-Willi Syndrome |
| Lead sponsor | University of British Columbia, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperphagia, Prader-Willi Syndrome |
| Intervention type | Drug |
| Interventions | Sandostatin LAR |
| Enrollment | 10 |
| Start date | Aug 1, 2004 |
| Completion | Oct 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 31, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: